-
Je něco špatně v tomto záznamu ?
Polymorphisms of TGF-beta1 in cystic fibrosis patients
J Brazova, K Sismova, V Vavrova, J Bartosova, M Jr Macek, H Lauschman, A Sediva
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem
Grantová podpora
NR8458
MZ0
CEP - Centrální evidence projektů
NI7486
MZ0
CEP - Centrální evidence projektů
NR7974
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Plný text - Část
Zdroj
Zdroj
NLK
ScienceDirect (archiv)
od 1999-01-01 do 2009-12-31
- MeSH
- cystická fibróza epidemiologie genetika metabolismus patologie MeSH
- dítě MeSH
- dospělí MeSH
- fenotyp MeSH
- genotyp MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- polymorfismus genetický * genetika MeSH
- předškolní dítě MeSH
- transformující růstový faktor beta1 * genetika metabolismus MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
There is a significant phenotypic variance among cystic fibrosis (CF) patients. Due to the role of TGF-beta1 in fibrotic processes we investigated its role in CF pathogenesis. TGF-beta 1 codons 10 and 25 were genotyped in 118 Czech CF patients and 268 controls by PCR-ARMS. Difference between CF and controls was found at codon 10, lower frequency of T/T homozygotes, and codon 25, higher frequency of G/C heterozygotes. We did not prove the association of TGF-beta1 polymorphisms and lung function in CF, however, the TT (codon 10)/GG (codon 25) genotype was preferentially associated with CF-related liver disease and diabetes. Independent of the TGF-beta1 genotype, production of cytokine was higher in patients than in controls with the notable exception of very low levels in Burkholderia cepacia complex colonized patients. In CF, both extremes, highest or lowest TGF-beta 1 production, were associated with impaired lung function.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13009622
- 003
- CZ-PrNML
- 005
- 20130729074728.0
- 007
- ta
- 008
- 130312s2006 xxud f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.clim.2006.08.015 $2 doi
- 035 __
- $a (PubMed)17052957
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Brázová, Jitka $7 xx0082231 $u Institute of Immunology, University Hospital Motol, Charles University, Prague, V Uvalu 84, 150 06 Prague 5, Czech Republic
- 245 10
- $a Polymorphisms of TGF-beta1 in cystic fibrosis patients / $c J Brazova, K Sismova, V Vavrova, J Bartosova, M Jr Macek, H Lauschman, A Sediva
- 520 9_
- $a There is a significant phenotypic variance among cystic fibrosis (CF) patients. Due to the role of TGF-beta1 in fibrotic processes we investigated its role in CF pathogenesis. TGF-beta 1 codons 10 and 25 were genotyped in 118 Czech CF patients and 268 controls by PCR-ARMS. Difference between CF and controls was found at codon 10, lower frequency of T/T homozygotes, and codon 25, higher frequency of G/C heterozygotes. We did not prove the association of TGF-beta1 polymorphisms and lung function in CF, however, the TT (codon 10)/GG (codon 25) genotype was preferentially associated with CF-related liver disease and diabetes. Independent of the TGF-beta1 genotype, production of cytokine was higher in patients than in controls with the notable exception of very low levels in Burkholderia cepacia complex colonized patients. In CF, both extremes, highest or lowest TGF-beta 1 production, were associated with impaired lung function.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a mladiství $7 D000293
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a dítě $7 D002648
- 650 02
- $a předškolní dítě $7 D002675
- 650 02
- $a cystická fibróza $x epidemiologie $x genetika $x metabolismus $x patologie $7 D003550
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a genotyp $7 D005838
- 650 02
- $a lidé $7 D006801
- 650 02
- $a kojenec $7 D007223
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a fenotyp $7 D010641
- 650 12
- $a polymorfismus genetický $x genetika $7 D011110
- 650 12
- $a transformující růstový faktor beta1 $x genetika $x metabolismus $7 D053773
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šišmová, Kristýna. $7 xx0222723 $u Institute of Immunology, University Hospital Motol, Charles University, Prague, V Uvalu 84, 150 06 Prague 5, Czech Republic
- 700 1_
- $a Vávrová, Věra, $d 1928- $7 nlk19990074045 $u Paediatric Department, University Hospital Motol, Charles University, Prague, Czech Republic
- 700 1_
- $a Bartošová, Jana $7 xx0082230 $u Paediatric Department, University Hospital Motol, Charles University, Prague, Czech Republic
- 700 1_
- $a Macek, Milan, $d 1961- $7 mzk2006348713 $u Institute of Biology and Medical Genetics, University Hospital Motol, Charles University, Prague, Czech Republic
- 700 1_
- $a Lauschmann, Hynek. $7 _AN048571 $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University, Prague, Czech Republic
- 700 1_
- $a Šedivá, Anna, $d 1955- $7 xx0000191 $u Institute of Immunology, University Hospital Motol, Charles University, Prague, V Uvalu 84, 150 06 Prague 5, Czech Republic
- 773 0_
- $t Clinical Immunology $x 1521-6616 $g Roč. 121, č. 3 (2006), s. 350-357 $p Clin Immunol $w MED00005218
- 773 0_
- $p Clin Immunol $g 121(3):350-357, 2006 Dec $x 1521-6616
- 910 __
- $a ABA008 $b B 1440 $y 3 $z 0
- 990 __
- $a 20130312142438 $b ABA008
- 991 __
- $a 20130729075222 $b ABA008
- 999 __
- $a ok $b bmc $g 972445 $s 807881
- BAS __
- $a 3
- BMC __
- $x MED00005218 $i 1521-6616 $a 2006 $b 121 $c 3 $d 350-357 $m Clinical immunology $n Clin Immunol
- GRA __
- $a NR8458 $p MZ0
- GRA __
- $a NI7486 $p MZ0
- GRA __
- $a NR7974 $p MZ0
- LZP __
- $c NLK115 $d 20130313 $a 2013-03/gvlm